AXSOME THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
AXSOME THERAPEUTICS, INC. (AXSM) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.64 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-02-23
- AXSOME THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-03-31 was $1.01M.
- AXSOME THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $1.64M, a 97.94% increase from fiscal 2022.
- AXSOME THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $826.00K.
- AXSOME THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $264.39K, a 8.02% increase from fiscal 2015.
- AXSOME THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2015 was $244.77K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2023-12-31 | $1.64M 10-K · filed 2026-02-23 | |
| 2023-03-31 | $1.01M 10-Q · filed 2024-05-06 | |
| 2022-12-31 | $826.00K 10-K · filed 2025-02-18 | |
| 2016-12-31 | $264.39K 10-K · filed 2017-03-07 | |
| 2015-12-31 | $244.77K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |